Consolidated Statements of Operations - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | ||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2019 |
Sep. 30, 2019 |
Jun. 30, 2019 |
Mar. 31, 2019 |
Dec. 31, 2018 |
Sep. 30, 2018 |
Jun. 30, 2018 |
Mar. 31, 2018 |
Sep. 30, 2017 |
Jun. 30, 2017 |
Mar. 31, 2017 |
Sep. 30, 2016 |
Jun. 30, 2016 |
Mar. 31, 2016 |
Sep. 30, 2015 |
Jun. 30, 2015 |
Mar. 31, 2015 |
Sep. 30, 2014 |
Dec. 31, 2019 |
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
|||||||||||||||||
| Income Statement [Abstract] | ||||||||||||||||||||||||||||||||||||||||
| Revenue, net | $ 24,220 | $ 21,896 | ||||||||||||||||||||||||||||||||||||||
| Cost of revenue (excluding amortization of $3,989 and $3,589, respectively) | 15,888 | 10,197 | ||||||||||||||||||||||||||||||||||||||
| Gross profit | 8,332 | 11,699 | ||||||||||||||||||||||||||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||||||||||||||||||
| Sales and marketing | 11,116 | 8,421 | ||||||||||||||||||||||||||||||||||||||
| Research and development | 2,810 | 2,124 | ||||||||||||||||||||||||||||||||||||||
| General and administrative | 14,363 | 8,676 | ||||||||||||||||||||||||||||||||||||||
| Acquisition related expense | 2,534 | |||||||||||||||||||||||||||||||||||||||
| Acquisition related amortization expense | 3,989 | 3,589 | ||||||||||||||||||||||||||||||||||||||
| Change in fair value of contingent consideration | (44) | 1,522 | ||||||||||||||||||||||||||||||||||||||
| Total operating expenses | 34,768 | 24,332 | ||||||||||||||||||||||||||||||||||||||
| Operating loss | (26,436) | (12,633) | ||||||||||||||||||||||||||||||||||||||
| Accretion expense | (440) | (331) | ||||||||||||||||||||||||||||||||||||||
| Other income (expense), net | 196 | 263 | ||||||||||||||||||||||||||||||||||||||
| Loss from continuing operations before tax | (26,680) | (12,701) | ||||||||||||||||||||||||||||||||||||||
| (Benefit) provision for income taxes | (28) | 18 | ||||||||||||||||||||||||||||||||||||||
| Loss from continuing operations | (26,652) | (12,719) | ||||||||||||||||||||||||||||||||||||||
| Income from discontinued operations, net of tax | (88) | 16 | ||||||||||||||||||||||||||||||||||||||
| Net loss | $ (10,663) | $ (7,446) | $ (5,304) | $ (3,326) | $ (4,299) | $ (3,126) | $ (2,001) | $ (3,277) | $ (3,400) | $ (6,390) | $ 2,330 | $ (8,003) | $ (2,844) | $ (5,296) | $ (5,405) | $ (7,488) | $ (4,614) | $ (4,454) | (26,740) | (12,703) | $ 12,553 | $ (22,003) | $ (13,623) | $ (16,768) | ||||||||||||||||
| Less dividends on preferred stock | (429) | |||||||||||||||||||||||||||||||||||||||
| Net loss attributable to common stockholders | $ (27,169) | $ (12,703) | ||||||||||||||||||||||||||||||||||||||
| Basic and diluted (loss) income per share of common stock: | ||||||||||||||||||||||||||||||||||||||||
| From continuing operations | $ (7.23) | $ (4.52) | ||||||||||||||||||||||||||||||||||||||
| From discontinued operations | (0.02) | |||||||||||||||||||||||||||||||||||||||
| Net loss per basic and diluted share of common stock | $ (1.54) | [1] | $ (6.61) | [1] | $ 5.32 | [1] | $ (43.97) | [1] | $ (15.63) | [1] | $ (29.75) | [1] | $ (34.43) | [1] | $ (49.26) | [1] | $ (30.76) | [1] | $ (29.89) | [1] | $ (7.25) | $ (4.52) | $ (7.96) | [1] | $ (120.90) | [1] | $ (87.95) | [1] | $ (112.53) | [1] | ||||||||||
| Weighted average number of common shares and common share equivalents outstanding: | ||||||||||||||||||||||||||||||||||||||||
| Basic | 3,746,000 | 2,816,000 | ||||||||||||||||||||||||||||||||||||||
| Diluted | 3,746,000 | 2,816,000 | ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares. No definition available.
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per basic and diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation, when the per share amount is the same. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|